From our previous website’s article collection. Dates, prices and treatment information reflect the original publication period.
Quick Answer: Filler complications are classified as early (<24 hours), late (24 hours–4 weeks) and very late (>4 weeks). Vascular occlusion — the most urgent complication — manifests immediately after injection with blanching and pain, requiring immediate hyaluronidase application. Late complications such as granuloma and biofilm require different treatment protocols.Complication Classification: Three Phases by Time
The most practical way to understand filler complications is to classify them according to their time of onset. This classification guides both diagnosis and treatment approach.
| Phase | Time Frame | Main Complications | Urgency |
|---|---|---|---|
| Early | < 24 hours | Vascular occlusion, pain, bruising, swelling, asymmetry | Emergency |
| Late | 24 hours – 4 weeks | Tyndall effect, nodule, infection, herpetic reactivation | Moderate |
| Very Late | > 4 weeks | Granuloma, biofilm infection, delayed inflammatory reaction, filler migration | Elective |
Vascular Occlusion: The Most Serious Complication
Vascular occlusion occurs when injected filler blocks a vessel or compresses it with external pressure. This disrupts blood supply to the affected area and creates a risk of necrosis (tissue death). The risk of vision loss is possible due to retrograde spread to intracranial arteries — this is extremely rare but can be prevented.
| Sign | Cause | Treatment |
|---|---|---|
| Sudden blanching, pallor of skin color | Intra-vascular injection or ischemia from pressure | Immediate hyaluronidase (150–300 IU), heat, massage, aspirin |
| Sudden severe pain | Increased intravascular pressure | Stop procedure, prepare hyaluronidase |
| Blurred vision, unilateral vision loss | Retrograde spread to supratrochlear/angular artery | Call emergency services, retrobulbar hyaluronidase, emergency ophthalmology |
Tyndall Effect: Blue-Purple Discoloration
The Tyndall effect is an optical phenomenon that occurs when hyaluronic acid filler is placed too close to the skin surface (superficially). The filler scatters light and appears as a blue or purple color through the skin. It is most commonly encountered in the under-eye (tear trough) area.
- Why it occurs: Superficial rather than deep placement; more pronounced in thin skin
- Treatment: Selective dissolution with hyaluronidase (20–50 IU, superficial injection); reversible
- Prevention: Use of low viscosity product in the under-eye area, application at deep periosteal plane
Granuloma: Late Foreign Body Reaction
Granulomas are masses that form as a result of a chronic inflammatory response to filler material. They can appear months or even years after injection. They are more common with permanent (non-HA) fillers; however, they have also been reported with HA fillers.
- Signs: Firm, painless nodules; sometimes accompanied by redness and swelling
- Treatment: Intralesional corticosteroid (combination with 5-fluorouracil); hyaluronidase for HA granulomas; surgical excision for resistant cases
- Risk factors: Use of permanent filler, repeated injection to the same area, immune system activation (post-vaccine, post-infection)
Biofilm Infection: An Insidious, Late-Onset Threat
A biofilm is a protective structure formed by bacteria on filler material. It is resistant to classical antibiotic treatment and infection signs can remain silent for months. Distinguishing it from acute infection is critical.
| Feature | Acute Infection | Biofilm |
|---|---|---|
| Onset time | < 2 weeks | Weeks–years |
| Pain | Pronounced | Mild–moderate |
| Warmth | Present | Minimal |
| Treatment | Antibiotics + drainage | Long-term antibiotics + hyaluronidase + rarely surgery |
Delayed Inflammatory Reaction (DLIR)
Delayed inflammatory reaction (DLIR) is characterized by swelling and redness appearing weeks or months after injection. It is frequently associated with a systemic immune activation trigger (viral infection, COVID-19, vaccine). It usually resolves on its own; in severe cases, oral corticosteroids or hyaluronidase are used.
Asymmetry and Nodule/Lumpiness
Asymmetry: May result from injection technique error, difference in edema or underlying anatomical asymmetry. Assessment is made after waiting 2–4 weeks; if persistent, it is corrected with targeted additional filler or hyaluronidase.
Nodule and lumpiness: Occurs due to non-homogeneous distribution of the product, superficial injection or application of high viscosity product to the wrong plane. It can be resolved with a massage protocol (2 weeks after injection), hyaluronidase or heat application.
Hyaluronidase Usage Protocol
Hyaluronidase is an enzyme that dissolves HA filler by hydrolysis. It is also known as an "eraser" in medical aesthetic clinics.
| Indication | Recommended Dose | Area | Repeat |
|---|---|---|---|
| Vascular occlusion (emergency) | 150–300 IU | Occlusion area + surroundings | Hourly, as needed |
| Tyndall / superficial filler | 20–50 IU | Affected area | Reassess after 1–2 weeks |
| Nodule / lumpiness | 30–75 IU | Within nodule | Every 2 weeks, 1–3 sessions |
| Full dissolution (to restart) | 150–300 IU / area | All affected area | Check after 2 weeks |
Note: An allergy test (especially in patients with bee venom allergy) should be performed before hyaluronidase application. Also, since the enzyme will affect the natural HA in the area, temporary loss of fullness should be expected; it returns to normal in 4–6 weeks.
Complication Risk Reduction Checklist
- Detailed medical history: blood thinners, autoimmune disease, active infection, allergy history
- Knowledge of anastomosis mapping and high-risk areas (glabellar, nasal, periorbital)
- Sterile technique: gloves, antisepsis, single-use materials
- Preference for cannula in high-risk areas; application of aspiration technique
- Slow, low-pressure injection; avoiding large boluses at a single point
- Use of CE/FDA approved, original products
- Availability of hyaluronidase in the clinic and knowledge of its use
- Patient briefing on "when to call?": alarm signs within 24 hours of the procedure
Patient Information: Alarm Signs Template
Any patient experiencing the following signs should contact the clinic as soon as possible:
- Blanching or mottled skin at the injection site
- Sudden severe, burning pain
- Blurred vision, double vision or vision loss
- Swelling and increased warmth in the area lasting more than 72 hours
- Redness accompanied by fever and general malaise
- Brown/purplish change in skin color (necrosis warning)
At Abel Beauty, physician support is available via WhatsApp for 7 days/24 hours after filler application.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.
